<p>加利福尼亞州門洛帕克，2025 年 12 月 23 日（GLOBE NEWSWIRE）-- BillionToOne, Inc.（納斯達克：BLLN），一家致力於創造強大且準確的分子診斷測試的下一代公司，今天宣佈公司管理層將參加第 44 屆摩根大通醫療會議。</p>
<p>管理層將於 2026 年 1 月 12 日（星期一）太平洋時間上午 9:45 至 10:25 進行演講。</p>
<p>BillionToOne 的投資者關係網站的 “活動與演示” 頁面將提供直播和存檔的網絡廣播，網址為 https://investors.billiontoone.com/news-events/events-presentations。</p>
<p><strong>關於 BillionToOne</strong></p>
<p>BillionToOne 總部位於加利福尼亞州門洛帕克，是一家致力於創造強大且準確的分子診斷測試的公司。該公司的專利定量計數模板™（QCT™）分子計數平台是唯一能夠在單分子水平上準確計數 DNA 分子的多重技術。欲瞭解更多信息，請訪問 www.billiontoone.com。</p>
<p><strong>投資者聯繫</strong></p>
<p>ir@billiontoone.com</p>
<p><strong>媒體聯繫</strong></p>
<p>billiontoone@moxiegrouppr.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeE5qSTVNQ00zTXpNek9UUXdJekl5T0RZd05URT0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeE5qSTVNQ00zTXpNek9UUXdJekl5T0RZd05URT0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MjViMjQwNjctYzFlOS00YjBjLTkyMDktY2ZkNTc3ZGU2MDcyLTEyOTc2MDEtMjAyNS0xMi0yMy1lbg==/tiny/BillionToOne-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MjViMjQwNjctYzFlOS00YjBjLTkyMDktY2ZkNTc3ZGU2MDcyLTEyOTc2MDEtMjAyNS0xMi0yMy1lbg==/tiny/BillionToOne-Inc-.png"/></p>

BLLN

<p>BillionToOne, Inc.（納斯達克代碼：BLLN），一家分子診斷公司，將參加第 44 屆摩根大通醫療會議。公司的管理層將在 2026 年 1 月 12 日進行演講。其投資者關係網站將提供直播和錄播網絡廣播。BillionToOne 以其定量計數模板™（QCT™）技術而聞名，該技術能夠在單分子水平上準確計數 DNA 分子</p>

<p>MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference.</p>
<div class="lb-trans"><p>加利福尼亞州門洛帕克，2025 年 12 月 23 日（GLOBE NEWSWIRE）-- BillionToOne, Inc.（納斯達克：BLLN），一家致力於創造強大且準確的分子診斷測試的下一代公司，今天宣佈公司管理層將參加第 44 屆摩根大通醫療會議。</p>
</div><p>Management will present from 9:45am to 10:25am Pacific Time on Monday, January 12th, 2026.</p>
<div class="lb-trans"><p>管理層將於 2026 年 1 月 12 日（星期一）太平洋時間上午 9:45 至 10:25 進行演講。</p>
</div><p>A live and archived webcast will be available on the “Events &amp; Presentations” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/news-events/events-presentations.</p>
<div class="lb-trans"><p>BillionToOne 的投資者關係網站的 “活動與演示” 頁面將提供直播和存檔的網絡廣播，網址為 https://investors.billiontoone.com/news-events/events-presentations。</p>
</div><p><strong>About BillionToOne</strong></p>
<div class="lb-trans"><p><strong>關於 BillionToOne</strong></p>
</div><p>Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.</p>
<div class="lb-trans"><p>BillionToOne 總部位於加利福尼亞州門洛帕克，是一家致力於創造強大且準確的分子診斷測試的公司。該公司的專利定量計數模板™（QCT™）分子計數平台是唯一能夠在單分子水平上準確計數 DNA 分子的多重技術。欲瞭解更多信息，請訪問 www.billiontoone.com。</p>
</div><p><strong>Investor Contact</strong></p>
<div class="lb-trans"><p><strong>投資者聯繫</strong></p>
</div><p>ir@billiontoone.com</p>
<div class="lb-trans"><p>ir@billiontoone.com</p>
</div><p><strong>Media Contact</strong></p>
<div class="lb-trans"><p><strong>媒體聯繫</strong></p>
</div><p>billiontoone@moxiegrouppr.com</p>
<div class="lb-trans"><p>billiontoone@moxiegrouppr.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeE5qSTVNQ00zTXpNek9UUXdJekl5T0RZd05URT0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYxNjI5MCM3MzMzOTQwIzIyODYwNTE="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MjViMjQwNjctYzFlOS00YjBjLTkyMDktY2ZkNTc3ZGU2MDcyLTEyOTc2MDEtMjAyNS0xMi0yMy1lbg==/tiny/BillionToOne-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/MjViMjQwNjctYzFlOS00YjBjLTkyMDktY2ZkNTc3ZGU2MDcyLTEyOTc2MDEtMjAyNS0xMi0yMy1lbg==/tiny/BillionToOne-Inc-.png"/></p>

BillionToOne 將參加第 44 屆摩根大通年度醫療健康大會 | BLLN 股票新聞